{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:06:28Z","timestamp":1790467588741,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T00:00:00Z","timestamp":1314230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/hr.2011.139","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T06:06:06Z","timestamp":1314252366000},"page":"34-40","source":"Crossref","is-referenced-by-count":65,"title":["The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice"],"prefix":"10.1038","volume":"35","author":[{"given":"Takanori","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukatsu","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Hanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenei","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,25]]},"reference":[{"key":"BFhr2011139_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","volume":"24","author":"DA Duprez","year":"2006","unstructured":"Duprez DA . Role of the renin\u2013angiotensin\u2013aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24: 983\u2013991.","journal-title":"J Hypertens"},{"key":"BFhr2011139_CR2","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK . Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82\u2013C97.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFhr2011139_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00041552-200503000-00007","volume":"14","author":"RM Touyz","year":"2005","unstructured":"Touyz RM . Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005; 14: 125\u2013131.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFhr2011139_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","volume":"52","author":"S Kim","year":"2000","unstructured":"Kim S, Iwao H . Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11\u201334.","journal-title":"Pharmacol Rev"},{"key":"BFhr2011139_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1586\/ers.10.32","volume":"4","author":"A Azuma","year":"2010","unstructured":"Azuma A . Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis. Expert Rev Respir Med 2010; 4: 301\u2013310.","journal-title":"Expert Rev Respir Med"},{"key":"BFhr2011139_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","volume":"291","author":"SN Iyer","year":"1999","unstructured":"Iyer SN, Gurujeyalakshmi G, Giri SN . Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999; 291: 367\u2013373.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr2011139_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1517\/13543780903501539","volume":"19","author":"ME Cho","year":"2010","unstructured":"Cho ME, Kopp JB . Pirfenidone: an anti-fibrotic therapy for progressive kidney disease. Expert Opin Invest Drugs 2010; 19: 275\u2013283.","journal-title":"Expert Opin Invest Drugs"},{"key":"BFhr2011139_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrneph.2010.57","volume":"6","author":"AE Decleves","year":"2010","unstructured":"Decleves AE, Sharma K . New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol 2010; 6: 371\u2013380.","journal-title":"Nat Rev Nephrol"},{"key":"BFhr2011139_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2008090931","volume":"20","author":"SP RamachandraRao","year":"2009","unstructured":"RamachandraRao SP, Zhu Y, Ravasi T, McGowan TA, Toh I, Dunn SR, Okada S, Shaw MA, Sharma K . Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol 2009; 20: 1765\u20131775.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2011139_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1440-1681.2009.05262.x","volume":"36","author":"F Grizzi","year":"2009","unstructured":"Grizzi F . Pirfenidone: a potential therapeutic option in the treatment of liver fibrosis. Clin Exp Pharmacol Physiol 2009; 36: 961\u2013962.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2011139_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.bjp.0704539","volume":"135","author":"S Mirkovic","year":"2002","unstructured":"Mirkovic S, Seymour AM, Fenning A, Strachan A, Margolin SB, Taylor SM, Brown L . Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. Br J Pharmacol 2002; 135: 961\u2013968.","journal-title":"Br J Pharmacol"},{"key":"BFhr2011139_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mus.20590","volume":"34","author":"C Van Erp","year":"2006","unstructured":"Van Erp C, Irwin NG, Hoey AJ . Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle Nerve 2006; 34: 327\u2013334.","journal-title":"Muscle Nerve"},{"key":"BFhr2011139_CR13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.hrthm.2010.04.030","volume":"7","author":"DT Nguyen","year":"2010","unstructured":"Nguyen DT, Ding C, Wilson E, Marcus GM, Olgin JE . Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias. Heart Rhythm 2010; 7: 1438\u20131445.","journal-title":"Heart Rhythm"},{"key":"BFhr2011139_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/FJC.0b013e3181ce97f6","volume":"55","author":"A Backes","year":"2010","unstructured":"Backes A, Seay U, Sedding DG, Tillmanns HH, Braun-Dullaeus RC . Inhibition of matrix deposition: a new strategy for prevention of restenosis after balloon angioplasty. J Cardiovasc Pharmacol 2010; 55: 213\u2013218.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011139_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbrc.2007.01.012","volume":"354","author":"I Burghardt","year":"2007","unstructured":"Burghardt I, Tritschler F, Opitz CA, Frank B, Weller M, Wick W . Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun 2007; 354: 542\u2013547.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFhr2011139_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejphar.2006.03.007","volume":"536","author":"A Dosanjh","year":"2006","unstructured":"Dosanjh A . Pirfenidone: anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. Eur J Pharmacol 2006; 536: 219\u2013222.","journal-title":"Eur J Pharmacol"},{"key":"BFhr2011139_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","volume":"171","author":"A Azuma","year":"2005","unstructured":"Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Kudoh S . Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171: 1040\u20131047.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFhr2011139_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/hr.2009.28","volume":"32","author":"Y Izumi","year":"2009","unstructured":"Izumi Y, Okatani H, Shiota M, Nakao T, Ise R, Kito G, Miura K, Iwao H . Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates. Hypertens Res 2009; 32: 339\u2013346.","journal-title":"Hypertens Res"},{"key":"BFhr2011139_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/01.RES.0000100665.67510.F5","volume":"93","author":"Y Izumiya","year":"2003","unstructured":"Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H . Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 2003; 93: 874\u2013883.","journal-title":"Circ Res"},{"key":"BFhr2011139_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1291\/hypres.27.771","volume":"27","author":"S Kim-Mitsuyama","year":"2004","unstructured":"Kim-Mitsuyama S, Izumi Y, Izumiya Y, Yoshida K, Yoshiyama M, Iwao H . Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. Hypertens Res 2004; 27: 771\u2013779.","journal-title":"Hypertens Res"},{"key":"BFhr2011139_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","volume":"106","author":"F Kuwahara","year":"2002","unstructured":"Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T . Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130\u2013135.","journal-title":"Circulation"},{"key":"BFhr2011139_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/01.RES.67.4.787","volume":"67","author":"D Chapman","year":"1990","unstructured":"Chapman D, Weber KT, Eghbali M . Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res 1990; 67: 787\u2013794.","journal-title":"Circ Res"},{"key":"BFhr2011139_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.RES.69.2.483","volume":"69","author":"M Eghbali","year":"1991","unstructured":"Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B . Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 1991; 69: 483\u2013490.","journal-title":"Circ Res"},{"key":"BFhr2011139_CR24","first-page":"H1861","volume":"262","author":"FJ Villarreal","year":"1992","unstructured":"Villarreal FJ, Dillmann WH . Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992; 262: H1861\u2013H1866.","journal-title":"Am J Physiol"},{"key":"BFhr2011139_CR25","doi-asserted-by":"publisher","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","volume":"283","author":"S Rosenkranz","year":"2002","unstructured":"Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schluter KD, Bohm M . Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 2002; 283: H1253\u2013H1262.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2011139_CR26","first-page":"779","volume":"125","author":"SN Iyer","year":"1995","unstructured":"Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB, Giri SN . Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 1995; 125: 779\u2013785.","journal-title":"J Lab Clin Med"},{"key":"BFhr2011139_CR27","first-page":"S239","volume":"63","author":"T Shimizu","year":"1997","unstructured":"Shimizu T, Fukagawa M, Kuroda T, Hata S, Iwasaki Y, Nemoto M, Shirai K, Yamauchi S, Margolin SB, Shimizu F, Kurokawa K . Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy. Kidney Int Suppl 1997; 63: S239\u2013S243.","journal-title":"Kidney Int Suppl"},{"key":"BFhr2011139_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1046\/j.1440-1681.2001.03481.x","volume":"28","author":"S Tada","year":"2001","unstructured":"Tada S, Nakamuta M, Enjoji M, Sugimoto R, Iwamoto H, Kato M, Nakashima Y, Nawata H . Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Clin Exp Pharmacol Physiol 2001; 28: 522\u2013527.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2011139_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0940-2993(11)80261-7","volume":"47","author":"H Suga","year":"1995","unstructured":"Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, Margolin S . Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp Toxicol Pathol 1995; 47: 287\u2013291.","journal-title":"Exp Toxicol Pathol"},{"key":"BFhr2011139_CR30","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","volume":"114","author":"KW Lee","year":"2006","unstructured":"Lee KW, Everett THt, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE . Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 2006; 114: 1703\u20131712.","journal-title":"Circulation"},{"key":"BFhr2011139_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1253\/circj.CJ-10-0272","volume":"74","author":"Y Sata","year":"2010","unstructured":"Sata Y, Krum H . The future of pharmacological therapy for heart failure. Circ J 2010; 74: 809\u2013817.","journal-title":"Circ J"},{"key":"BFhr2011139_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cardiores.2007.02.008","volume":"74","author":"M Ruiz-Ortega","year":"2007","unstructured":"Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J . TGF-beta signaling in vascular fibrosis. Cardiovasc Res 2007; 74: 196\u2013206.","journal-title":"Cardiovasc Res"},{"key":"BFhr2011139_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1291\/hypres.29.711","volume":"29","author":"H Kai","year":"2006","unstructured":"Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T . Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 2006; 29: 711\u2013718.","journal-title":"Hypertens Res"},{"key":"BFhr2011139_CR34","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/01.HYP.30.6.1397","volume":"30","author":"Qt Capers","year":"1997","unstructured":"Capers Qt, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR . Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997; 30: 1397\u20131402.","journal-title":"Hypertension"},{"key":"BFhr2011139_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0021-9150(99)00346-9","volume":"147","author":"TJ Reape","year":"1999","unstructured":"Reape TJ, Groot PH . Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213\u2013225.","journal-title":"Atherosclerosis"},{"key":"BFhr2011139_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.gt.3302670","volume":"13","author":"S Kim-Mitsuyama","year":"2006","unstructured":"Kim-Mitsuyama S, Izumi Y, Izumiya Y, Namba M, Yoshida K, Wake R, Yoshiyama M, Iwao H . Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension. Gene Therapy 2006; 13: 348\u2013355.","journal-title":"Gene Therapy"},{"key":"BFhr2011139_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cmet.2007.01.003","volume":"5","author":"M Sano","year":"2007","unstructured":"Sano M, Izumi Y, Helenius K, Asakura M, Rossi DJ, Xie M, Taffet G, Hu L, Pautler RG, Wilson CR, Boudina S, Abel ED, Taegtmeyer H, Scaglia F, Graham BH, Kralli A, Shimizu N, Tanaka H, Makela TP, Schneider MD . Menage-a-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1. Cell Metab 2007; 5: 129\u2013142.","journal-title":"Cell Metab"},{"key":"BFhr2011139_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00109-008-0323-5","volume":"86","author":"CA Lemarie","year":"2008","unstructured":"Lemarie CA, Paradis P, Schiffrin EL . New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med 2008; 86: 673\u2013678.","journal-title":"J Mol Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2011139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T07:42:06Z","timestamp":1741506126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2011139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFhr2011139"],"URL":"https:\/\/doi.org\/10.1038\/hr.2011.139","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,25]]}}}